Soru

Zorluk: ZorReproductive Endocrinology and Infertility

Match each of the following clinical presentations of patients experiencing secondary amenorrhea or oligomenorrhea with the primary pathophysiological mechanism responsible for their reproductive endocrine dysfunction.

  • Patient with a BMI of 17.2 kg/m² presenting with a recent metatarsal stress fracture and 6 months of absent menses. Laboratory evaluation shows low serum estradiol and unmeasurable luteinizing hormone.Suppression of pulsatile hypothalamic gonadotropin-releasing hormone release secondary to physiological stress or energy deficit.
  • Patient with recent onset of severe dyspareunia, vasomotor symptoms, and cessation of menses at age 33. Laboratory testing reveals elevated follicle-stimulating hormone and decreased anti-Müllerian hormone.Accelerated depletion of functional ovarian follicles resulting in loss of negative feedback to the pituitary.
  • Patient treated with risperidone for a psychiatric condition presenting with bilateral galactorrhea and secondary amenorrhea. Thyroid-stimulating hormone is normal, and pregnancy test is negative.Pharmacological antagonism of dopamine receptors removing inhibitory tone on pituitary lactotrophs.
  • Patient with irregular menses every 45-90 days, recalcitrant cystic acne, and a normal body mass index. Pelvic examination is unremarkable, but serum free testosterone is elevated.Altered gonadotropin secretion patterns combined with intrinsic ovarian hyperandrogenemia.

Cevap

The low-BMI patient matches with hypothalamic suppression; the patient with elevated FSH and low AMH matches with accelerated follicular depletion; the patient taking risperidone matches with pharmacological dopamine antagonism; and the normoweight patient with hyperandrogenism matches with altered gonadotropin secretion and intrinsic ovarian hyperandrogenemia.
Each clinical presentation describes a distinct etiology of reproductive dysfunction requiring specific pathophysiological correlation. Functional hypothalamic amenorrhea is driven by central energy deficits suppressing GnRH. Primary ovarian insufficiency is a peripheral failure caused by premature follicular depletion. Medication-induced hyperprolactinemia results from dopamine receptor blockade. Polycystic ovary syndrome represents an intrinsic disorder of ovarian androgen production and altered pituitary gonadotropin ratios.

Adım Adım Çözüm

1
Analyze the patient with low BMI and a stress fracture.
Identify functional hypothalamic amenorrhea (FHA), matching with suppression of pulsatile GnRH release.
Relative energy deficiency causes the hypothalamus to decrease GnRH pulsatility, leading to low gonadotropins and hypoestrogenism (causing bone loss).
2
Evaluate the 33-year-old patient with dyspareunia, vasomotor symptoms, and high FSH.
Identify primary ovarian insufficiency (POI), matching with accelerated depletion of functional ovarian follicles.
Loss of ovarian follicles decreases estrogen and inhibin B production, removing negative feedback and driving FSH levels upward.
3
Assess the patient taking risperidone who developed galactorrhea.
Identify medication-induced hyperprolactinemia, matching with pharmacological antagonism of dopamine receptors.
Antipsychotics block dopamine D2 receptors on lactotrophs, lifting the normal inhibition of prolactin secretion and causing secondary hypogonadism.
4
Examine the patient with acne, oligomenorrhea, and elevated testosterone despite a normal BMI.
Identify lean-phenotype polycystic ovary syndrome (PCOS), matching with altered gonadotropin secretion and intrinsic hyperandrogenemia.
PCOS is fundamentally an endocrine disorder of androgen excess and ovulatory dysfunction, which can occur independently of obesity.

Anahtar Kavram

Differential diagnosis and pathophysiology of secondary amenorrhea and oligomenorrhea.
Bu soruyu puanla